ARK Diagnostics is a global leader in developing and manufacturing high-quality In Vitro Diagnostic (IVD) tests for Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DoA). Using advanced EMIT® immunoassay technology, ARK Diagnostics provides fast, reliable, and automated testing solutions for human and veterinary laboratories worldwide. Its expertise in antibody-conjugate pairing ensures exceptional accuracy and consistency across all assays. Founded in 2003, ARK Diagnostics partners with major clinical chemistry platforms to deliver easy-to-use, high-performance assays. Driven by innovation and quality, ARK Diagnostics empowers healthcare professionals to make safer, more effective treatment decisions every day.